First-pass extracted concept

photosensitizing agent

Candidate: concept label2 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

A photosensitizing agent is the light-responsive component administered before illumination in PDT.

Source 2DOI PubMed

Resources required

It requires administration and subsequent exposure to light of a specific wavelength; some cases may require metabolic synthesis from a prodrug.

Source 2DOI PubMed

What problem it solves

It enables the photochemical and photobiologic reactions that damage tumor tissue during PDT.

Source 2DOI PubMed

What it does not solve

The abstract does not support any one photosensitizer as universally effective or sufficient without proper localization and dosimetry.

Source 2DOI PubMed

Alternatives

Photofrin is named as one specific example within the broader class of photosensitizing agents.

Source 2DOI PubMed

Evidence Snippets

The procedure involves administration of a photosensitizing agent followed by irradiation at a wavelength corresponding to an absorbance band of the sensitizer.

Evidence 1Source 1DOI PubMedprovenance

Photodynamic therapy involves administration of a tumor-localizing photosensitizing agent, which may require metabolic synthesis (i.e., a prodrug), followed by activation of the agent by light of a specific wavelength.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1review2011CA A Cancer Journal for CliniciansDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2review1998JNCI Journal of the National Cancer InstituteDOI PubMed

1 evidence snippet 2 linked claims Claim 1 Claim 2

Linked Claims

Claim 1mechanism summarysupports2011Source 1DOI PubMed

Photodynamic therapy involves administration of a photosensitizing agent followed by wavelength-matched irradiation.

Claim 2mechanism summarysupports1998Source 2DOI PubMed

Photodynamic therapy consists of administering a tumor-localizing photosensitizing agent, sometimes generated through prodrug metabolism, followed by activation with light of a specific wavelength.

Claim 3review scope summarysupports1998Source 2DOI PubMed

The review discusses mechanisms of subcellular and tumor localization of photosensitizing agents, molecular and cellular tumor responses to photodynamic therapy, and technical issues in light dosimetry.